What is the current price of AIML.CN stock and its trading status?

AIML.CN stock is trading at **C$0.04** on CNQ during market hours on 23 Feb 2026 with volume **183,250**, below its 50-day average. The listing shows thin liquidity and both day low and high at C$0.04.

What are the main valuation concerns for AIML.CN stock?

Valuation concerns include EPS **-0.03**, PE **-1.33**, price-to-sales **40.00** and price-to-book **5.23**, reflecting losses, tiny revenue, and a stretched valuation versus fundamentals. These metrics indicate high risk for investors.

What forecast does Meyka AI give for AIML.CN stock?

Meyka AI's forecast model projects **C$0.02** monthly and **C$0.0084** yearly for AIML.CN stock, implying downside of **-50.00%** and **-78.92%** respectively. Forecasts are model-based projections and not guarantees.

What catalysts could move AIML.CN stock higher?

Positive catalysts include commercial contracts for the monitoring system, clinical validation milestones, partnerships with healthcare providers, or broader AI-healthcare adoption. Any clear revenue trajectory would materially reduce risk.

CA Stocks

C$0.04 AI/ML Innovations (AIML.CN CNQ) 23 Feb 2026 Market Hours: risk signal

ByDanny Kontos February 23, 2026February 23, 2026

AIML.CN stock trades at C$0.04 on the CNQ during market hours on 23 Feb 2026, reflecting thin liquidity and large historical volatility. We note daily volume of 183,250 shares versus a 50-day average near 0.04 and a market cap of C$6,730,560.00, underscoring micro-cap status in Healthcare AI. Investors should weigh the firm’s patent-pending digital health proposition against negative earnings and limited free cash flow. As an AI-powered market analysis platform, Meyka AI monitors AIML.CN stock for short-term momentum and structural risks in the AI-healthcare niche.